相关实验视频

Updated: Jan 13, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

作为HIV-1非核酸逆转录酶抑制剂的新型二甲基胺衍生物的发现:设计,合成和生物活性评估

Hao Lin¹, Zhongxia Zhou², Lin Zheng¹

¹Department of Medicinal Chemistry, Shandong Key Laboratory of Druggability Optimization and Evaluation for Lead Compounds, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, PR China.

Bioorganic chemistry

|January 9, 2026

概括

研究人员开发了新的DAPY衍生物来对抗HIV-1,改进了以前的化合物. 化合物29显示对HIV-1菌株的高强度和增强的溶解性,提供了一个有前途的新型非核酸逆转录酶抑制剂 (NNRTI).

科学领域:

药用化学医学化学
病毒学病毒学
药物发现药物发现药物发现

背景情况:

之前的非核酸逆转录酶抑制剂 (NNRTIs),如K-5a2,对代谢稳定性和溶解性存在问题.
化合物XJ-56和XJ-90对特定的HIV-1突变菌株的疗效降低.

研究的目的:

使用碎片杂交设计和合成新的DAPY衍生品.
评估新化合物的抗HIV-1活性,酶抑制和物理化学特性.

主要方法:

为设计24种新型DAPY衍生品的碎片混合化策略.
在MT-4细胞中进行抗HIV-1活性测定.
酶抑制试验以确定作用机制.
测量水溶性的方法.
分子对接以阐明与逆转录酶 (RT) 的结合模式.

主要成果:

化合物29成为针对HIV-1 IIIB (EC50 = 1.38 nM) 的最强大的抑制剂.
化合物29对各种突变的HIV-1菌株 (EC50范围:1.61119nM) 显示出广泛的活性.
化合物29的水溶性得到显著改善 (S = 3.35μg/mL).
分子对接研究提供了关于DAPY衍生物与RT的结合相互作用的见解.

结论:

新型DAPY衍生物,特别是化合物29,代表了强大的HIV-1 NNRTIs.
碎片杂交是一种有效的策略,用于开发具有增强溶解性的改进的抗HIV-1药物.
化合物29需要进一步研究,因为它是HIV-1感染的潜在治疗候选者.

关键词:

达皮 (DAPY) 是一个有趣的词.艾滋病病毒-1 艾滋病病毒-1 分子杂交的分子杂交.没有NNIBP.没有NNRTIs的NNRTI

更多相关视频

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

相关概念视频

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...